187
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases

, , , &

References

  • Alelign, T.; Ahmed, M.; Bobosha, K.; Tadesse, Y.; Howe, R.; Petros, B. Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies. J. Immunol. Res. 2018, 1–18. DOI: 10.1155/2018/5986740.
  • Lefaucheur, C.; Viglietti, D.; Bentlejewski, C.; van Huyen JP; Vernerey D; Aubert O; Verine J; Jouven X; Legendre C; Glotz D;, et al. IgG Donor-specific Anti-human HLA Antibody Subclasses and Kidney Allograft Antibody-mediated Injury. J. Am. Soc. Nephrol. 2016, 27, 293–304.
  • Patel, R.; Terasaki, P. I. Significance of the Positive Crossmatch Test in Kidney Transplantation. N. Engl. J. Med. 1969, 280, 735–739. DOI: 10.1056/NEJM196904032801401.
  • Althaf, M. M.; El Kossi, M.; Jin, J. K.; Sharma, A.; Halawa, A. M. Human Leukocyte Antigen Typing and Crossmatch: A Comprehensive Review. World J. Transplant. 2017, 7(6), 339–348. DOI: 10.5500/wjt.v7.i6.339.
  • Baranwal, A. K.; Bhat, D. K.; Goswami, S.; Agarwal SK; Kaur G; Kaur J; Mehra N.  Comparative Analysis of Luminex-based Donor-specific Antibody Mean Fluorescence Intensity Values with Complement-dependent Cytotoxicity & Flow Crossmatch Results in Live Donor Renal Transplantation. Indian J. Med. Res. 2017, 145(2), 222–228. DOI: 10.4103/ijmr.IJMR_222_16.
  • Peng, B.; Zhuang, Q.; Yu, M.; Li, J.; Liu, Y.; Zhu, L.; Ming, Y. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome following Kidney Transplantation. Med. Sci. Monit. 2019, 25, 952–961. Published 2019 Feb 3. DOI:10.12659/MSM.914902
  • Batal, I.; Zeevi, A.; Lunz, J. G., 3rd; Aggarwal, N.; Shapiro, R.; Randhawa, P.; Girnita A.  Antihuman Leukocyte Antigen – Specific Antibody Strength Determined by Complement-dependent or Solid-phase Assays Can Predict Positive Donor-specific Crossmatches. Arch. Pathol. Lab. Med. 2010, 134, 1534–1540.
  • Moreno, C.; Burgos, L.; Pérez-Robles, C.; Delgado, J. A.; Mata, J. J.; Errasti, P.; Martín, P.; Merino, J.; Sánchez-Ibarrola, A. Predictive Value of the Luminex Single Antigen Panel for Detecting Flow Cytometry Cross-match Positivity. Hum. Immunol. 2012, 73, 517–521. DOI: 10.1016/j.humimm.2012.02.022.
  • Terasaki, P. I.; McClelland, J. D. Microdroplet Assay of Human Serum Cytotoxins. Nature. 1964, 204, 998. DOI: 10.1038/204998b0.
  • Terasaki PI. Sero-Typing of Human Lymphocyte Antigens: Preliminary Trials on Long-Term Kidney Homograft Survivors* Paul I. Terasaki, Thomas L. Marchioro, and Thomas E. Starzl Departments of Surgery University of California School of Medicine, Los Angeles. Histocompatibility testing. 1965;1229:83.
  • Tait, B. D.; Hudson, F.; Cantwell, L.; Brewin, G.; Holdsworth, R.; Bennett, G.; Jose, M. Review Article: Luminex Technology for HLA Antibody Detection in Organ Transplantation. Nephrology (Carlton). 2009, 14, 247–254.
  • South, A. M.; Grimm, P. C. Transplant Immuno-diagnostics: Crossmatch and Antigen Detection. Pediatr. Nephrol. 2016, 31, 897–905.
  • Eckels, D. D.; Stehlik, J.; Kfoury, A. G. The Detection and Role of Circulating Antibodies in Rejection. Curr. Opin. Organ Transplant. 2013, 18(5), 589–594. DOI: 10.1097/MOT.0b013e328364fe3d.
  • Gibney, E. M.; Cagle, L. R.; Freed, B.; Warnell, S. E.; Chan, L.; Wiseman, A. C. Detection of Donor-specific Antibodies Using HLA-coated Microspheres: Another Tool for Kidney Transplant Risk Stratification. Nephrol. Dial. Transplant. 2006, 21, 2625–2629. DOI: 10.1093/ndt/gfl202.
  • Tait, B. D.; Hudson, F.; Cantwell, L.; Brewin, G.; Holdsworth, R.; Bennett, G.; Jose, M. Review Article: Luminex Technology for HLA Antibody Detection in Organ Transplantation. Nephrology. 2009, 14, 247–254.
  • Lee, P. C.; Ozawa, M.; Hung, C. J.; Lin, Y.-J.; Chang, -S.-S.; Chou, T.-C. Reappraisal of HLA Antibody Analysis and Crossmatching in Kidney Transplantation. Transplant. Proc. 2009, 41, 95–98. DOI: 10.1016/j.transproceed.2008.10.074.
  • Konvalinka, A.; Tinckam, K. Utility of HLA Antibody Testing in Kidney Transplantation. J. Am. Soc. Nephrol. 2015, 26(7), 1489–1502. DOI: 10.1681/ASN.2014080837.
  • Tait, B. D.;. Detection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead Assay. Front. Immunol. 2016, 7, 570.
  • Susal, C.; Opelz, G.; Role, M. C. And Value of Luminex(®)-Detected HLA Antibodies before and after Kidney Transplantation. Transfus. Med. Hemother. 2013, 40(3), 190–195. DOI: 10.1159/000351314.
  • Althaf, M. M.; El Kossi, M.; Jin, J. K.; Sharma, A.; Halawa, A. M. Human Leukocyte Antigen Typing and Crossmatch: A Comprehensive Review. World J. Transplant. Dec 24 2017, 7(6), 339–348. PMID: 29312863; PMCID: PMC5743871. DOI: 10.5500/wjt.v7.i6.339
  • Lachmann, N.; Todorova, K.; Schulze, H.; Luminex(®, S. C. And Its Applications for Solid Organ Transplantation, Hematopoietic Stem Cell Transplantation, and Transfusion. Transfus. Med. Hemother. 2013, 40(3), 182–189. DOI: 10.1159/000351459.
  • Ravindranath, M. H.; Filippone, E. J.; Mahowald, G.; Callender, C.; Babu, A.; Saidman, S.; Ferrone, S. Significance of the Intraindividual Variability of HLA IgG Antibodies in Renal Disease Patients Observed with Different Beadsets Monitored with Two Different Secondary Antibodies on a Luminex Platform. Immunol. Res. 2018, 66, 584–604. DOI: 10.1007/s12026-018-9027-2.
  • Loiseau, P.; Amokhrane, K.; Visentin, J.; Kheav, V.-D.; Caillat-Zucman, S.; Taupin, J.-L. Use of Single-Antigen Flow Beads Assays to Assess Anti-HLA Donor-Specific Antibody Strength. Biol. Blood Marrow Transplant: J. Am. Soc. Blood Marrow Transplant. 2016 Feb, 22(2), 394–395. DOI:10.1016/j.bbmt.2015.11.006
  • Tait, B. D.; Süsal, C.; Gebel, H. M.; Nickerson, P. W.; Zachary, A. A.; Claas, F. H.; Reed EF; Bray RA; Campbell P; Chapman JR;, et al. Consensus Guidelines on the Testing and Clinical Management Issues Associated with HLA and non-HLA Antibodies in Transplantation. Transplantation. 2013, 95, 19–47.
  • Riethmüller, S.; Ferrari-Lacraz, S.; Mueller, M.; Raptis, D.; Hadaya, K.; Rüsi, B.; Laube, G.; Schneiter, G.; Fehr, T.; Villard, J. Donor-Specific Antibody Levels and Three Generations of Crossmatches to Predict Antibody-Mediated Rejection in Kidney Transplantation. Transplantation. 2010, 90, 160–167. DOI: 10.1097/TP.0b013e3181e36e08.
  • Rabab, A.; AlEssa, O.; Alzahrani, S.; Abduladheem, D.; Aqool, A. Correlation between the Strength of Donor Specific Antibody (DSA) Using Single Antigen Bead Assay (SAB) and the Results of CDC- Cytotoxicity and Flow Cytometric Crossmatch. Hum. Immunol. 2018, 79, 149. DOI: 10.1016/j.humimm.2018.07.176.
  • South, A. M.; Grimm, P. C. Transplant Immuno-diagnostics: Crossmatch and Antigen Detection. Pediatr. Nephrol. 2016, 31, 897–905.
  • Ting, A.; Morris, P. J. A Technique for Lymphocyte Preparation from Stored Heparinized Blood. Vox. Sang. 1971, 20(6), 561–563. DOI: 10.1159/000466675.
  • Reed, E. F.; Rao, P.; Zhang, Z.; Gebel, H.; Bray, R. A.; Guleria, I.; Lunz, J.; Mohanakumar, T.; Nickerson, P.; Tambur, A. R.; et al. Comprehensive Assessment and Standardization of Solid Phase Multiplex-bead Arrays for the Detection of Antibodies to HLA-drilling down on Key Sources of Variation. Am. J. Transplant. 2013, 13, 3050–3051. Doi:10.1111/ajt.12462.
  • Morrison, A. H.; Gupta, M.; Lloyd, K.; Trofe-Clark, J.; Ann Lim, M.; Limonte, C.; Levine, M. H.; Sawinski, D.; Kamoun, M.; Porrett, P. M.;, et al. Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients. Transplant. Direct. 2019 Aug, 5(8), e478. DOI:10.1097/TXD.0000000000000926.
  • Lucas, J. L.; Tacheny, E. A.; Ferris, A.; Galusha M; Srivastava AK; Ganguly A; Williams PM; Sachs MC; Thurin M; Tricoli JV;, et al. Development and Validation of a Luminex Assay for Detection of a Predictive Biomarker for PROSTVAC-VF Therapy. PLoS One. 2017, 12, 8.
  • Tait, B. D.; Susal, C.; Gebel, H. M.; Nickerson, P. W.; Zachary, A. A.; Claas, F. H. J.; Reed, E. F.; Bray, R. A.; Campbell, P.; Chapman, J. R.; et al. Consensus Guidelines on the Testing and Clinical Management Issues Associated with HLA and non-HLA Antibodies in Transplantation. Transplantation. 2013, 95, 19–47.
  • Vlad, G.; Ho, E. K.; Vasilescu, E. R.; Colovai AI; Stokes MB; Markowitz GS; D’Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N. Relevance of Different Antibody Detection Methods for the Prediction of Antibody-mediated Rejection and Deceased-donor Kidney Allograft Survival. Hum. Immunol. 2009, 70, 589–594.
  • Jindra, P. T.; Jin, Y. P.; Rozengurt, E.; Reed, E. F. HLA Class I Antibody-mediated Endothelial Cell Proliferation via the mTOR Pathway. J. Immunol. 2008, 180, 2357–2366. DOI: 10.4049/jimmunol.180.4.2357.
  • Jindra, P. T.; Zhang, X.; Mulder, A.; Claas, F.; Veale, J.; Jin, Y.-P.; Reed, E. F. Anti-HLA Antibodies Can Induce Endothelial Cell Survival or Proliferation Depending on Their Concentration. Transplantation. 2006, 82, 33–35. DOI: 10.1097/01.tp.0000231447.34240.3c.
  • Kraus, E. S.; Parekh, R. S.; Oberai, P.; Lepley, D.; Segev, D. L.; Bagnasco, S.; Collins, V.; Leffell, M.; Lucas, D.; Rabb, H.; et al. Subclinical Rejection in Stable Positive Crossmatch Kidney Transplant Patients: Incidence and Correlations. Am. J. Transplant. 2009, 9, 1826–1834. DOI: 10.1111/j.1600-6143.2009.02701.x.
  • McCaughan, J.; Xu, Q.; Tinckam, K. Detecting Donor-specific Antibodies: The Importance of Sorting the Wheat from the Chaff. Hepatobiliary Surg. Nutr. 2019, 8(1), 37–52. DOI: 10.21037/hbsn.2019.01.01.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.